Opinion

Video

BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer

Author(s):

John L. Marshall, MD,Benjamin Weinberg, MD

Pashtoon Murtaza Kasi, MD, MS, reviews data from the BESPOKE CRC study, highlighting overall results and patient-reported outcomes.

Related Videos
Arvind N. Dasari, MD, MS
4 experts are featured in this series.
Related Content
FDA
January 10th 2025

Abenacianine Wins FDA Fast Track Designation for Tumor Visualization in the Lung

Mazyar Shadman, MD, MPH, associate professor, Clinical Research Division, medical director, Cellular Immunotherapy, Fred Hutchinson Cancer Center
December 19th 2024

Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

FDA
January 8th 2025

Invikafusp Alfa Receives FDA Fast Track Designation for TMB-High CRC

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
October 24th 2024

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD

John L. Marshall, MD, of Georgetown Lombardi Comprehensive Cancer Center
December 26th 2024

Uncovering the Power of Introspection to Drive Personalized Cancer Care

Colorectal Cancer | stock.adobe.com
December 23rd 2024

Nivolumab Plus Ipilimumab Wins European Approval for MSI-H/dMMR mCRC